Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001493152-25-005174
Filing Date
2025-02-06
Accepted
2025-02-06 16:00:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5207
  Complete submission text file 0001493152-25-005174.txt   7232
Mailing Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477
Business Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Subject) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-80718 | Film No.: 25597239
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ROBERT S. LEVIN, ESQ., TRUSTEE 180 NORTH LASALLE STREET, SUITE 3200 CHICAGO IL 60601
Business Address C/O ROBERT S. LEVIN, ESQ., TRUSTEE 180 NORTH LASALLE STREET, SUITE 3200 CHICAGO IL 60601 312-368-0100
Francisco Trust under agreement dated February 28, 1996 (Filed by) CIK: 0001328329 (see all company filings)

EIN.: 000000000 | State of Incorp.: IL | Fiscal Year End: 1231
Type: SCHEDULE 13G